Compounds > ethosuximide

ethosuximide and 4-butyrolactone

ethosuximide has been researched along with 4-butyrolactone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Covey, DF; Ferrendelli, JA; Klunk, WE; McKeon, A1
Baba, H; Ono, K; Sugai, S1
Covey, DF; Ferrendelli, JA; Gross, RA1
Fukuda, H; Ishige, K; Ito, Y1
Aleem, IS; Ashraf, A; Cortez, MA; Kanawaty, A; Liu, CC; Sadeghnia, HR; Shen, L; Snead, OC; Stewart, L; Trepanier, CH; Wu, Y1
Bonifácio, MJ; Pires, NM; Soares-da-Silva, P1

Other Studies

6 other study(ies) available for ethosuximide and 4-butyrolactone

ArticleYear
Alpha-substituted gamma-butyrolactones: new class of anticonvulsant drugs.
    Science (New York, N.Y.), 1982, Sep-10, Volume: 217, Issue:4564

    Topics: 4-Butyrolactone; Animals; Anticonvulsants; Chemical Phenomena; Chemistry; Convulsants; Drug Evaluation, Preclinical; Electroencephalography; Epilepsy, Absence; Ethosuximide; Furans; Guinea Pigs; Mice; Structure-Activity Relationship; Trimethadione

1982
A new chronic model of spontaneous nonconvulsive generalized seizures.
    The Japanese journal of psychiatry and neurology, 1993, Volume: 47, Issue:2

    Topics: 4-Butyrolactone; Animals; Cerebral Cortex; Corpus Callosum; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized; Ethosuximide; Evoked Potentials; Injections, Intraperitoneal; Male; Phenytoin; Rats; Rats, Wistar; Seizures; Sodium Oxybate; Valproic Acid

1993
Voltage-dependent calcium channels as targets for convulsant and anticonvulsant alkyl-substituted thiobutyrolactones.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: 4-Butyrolactone; Animals; Animals, Newborn; Anticonvulsants; Calcium Channels; Cells, Cultured; Convulsants; Ethosuximide; Evoked Potentials; Ganglia, Spinal; Membrane Potentials; Neurons; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley

1997
Pharmacological profiles of absence seizure-induced increases in CRE- and AP-1 DNA-binding activities in gamma-butyrolactone-treated mice.
    Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 1998, Volume: 18, Issue:4

    Topics: 4-Butyrolactone; Activating Transcription Factor 2; Animals; Anticonvulsants; Brain; Brain Chemistry; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; DNA-Binding Proteins; Epilepsy, Absence; Ethosuximide; GABA Antagonists; Mice; Organophosphorus Compounds; Phosphinic Acids; Thalamus; Transcription Factor AP-1; Transcription Factors

1998
Infantile spasms and Down syndrome: a new animal model.
    Pediatric research, 2009, Volume: 65, Issue:5

    Topics: 4-Butyrolactone; Animals; Anticonvulsants; Baclofen; Brain; Disease Models, Animal; Down Syndrome; Electroencephalography; Ethosuximide; GABA Agonists; Genotype; Humans; Infant; Mice; Mice, Mutant Strains; Organophosphorus Compounds; Phenotype; Receptors, GABA-A; Receptors, GABA-B; Spasms, Infantile; Time Factors; Valproic Acid; Vigabatrin

2009
Carbamazepine aggravates absence seizures in two dedicated mouse models.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:5

    Topics: 4-Butyrolactone; Animals; Anticonvulsants; Calcium Channels, T-Type; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Ethosuximide; Male; Mice; Mice, Inbred Strains; Motor Activity; Patch-Clamp Techniques; Psychomotor Performance; Receptors, GABA-A

2015